Mettler-Toledo [MTD] vs Thermo Fisher [TMO] Detailed Stock Comparison
Mettler-Toledo
NYSE
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Mettler-Toledo wins in 9 metrics, Thermo Fisher wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Mettler-Toledo | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 33.22 | 28.25 | Thermo Fisher |
| Price-to-Book Ratio | N/A | 3.66 | N/A |
| Debt-to-Equity Ratio | -8.44 | 69.62 | Mettler-Toledo |
| PEG Ratio | 30.81 | 4.97 | Thermo Fisher |
| EV/EBITDA | 24.59 | 19.74 | Thermo Fisher |
| Profit Margin (TTM) | 21.46% | 15.24% | Mettler-Toledo |
| Operating Margin (TTM) | 27.37% | 17.84% | Mettler-Toledo |
| EBITDA Margin (TTM) | 27.37% | 17.84% | Mettler-Toledo |
| Return on Equity | -680.23% | 13.42% | Thermo Fisher |
| Return on Assets (TTM) | 20.82% | 4.97% | Mettler-Toledo |
| Free Cash Flow (TTM) | $864.45M | $7.27B | Thermo Fisher |
| Dividend Yield | N/A | 0.31% | N/A |
| 1-Year Return | -7.42% | -19.04% | Mettler-Toledo |
| Price-to-Sales Ratio (TTM) | 6.99 | 4.27 | Thermo Fisher |
| Enterprise Value | $29.16B | $213.59B | Thermo Fisher |
| EV/Revenue Ratio | 7.54 | 4.94 | Thermo Fisher |
| Gross Profit Margin (TTM) | 58.98% | 40.61% | Mettler-Toledo |
| Revenue per Share (TTM) | $185 | $114 | Mettler-Toledo |
| Earnings per Share (Diluted) | $39.50 | $17.31 | Mettler-Toledo |
| Beta (Stock Volatility) | 1.35 | 0.75 | Thermo Fisher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Mettler-Toledo vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mettler-Toledo | -0.10% | 4.49% | 12.30% | 14.78% | 3.08% | 7.50% |
| Thermo Fisher | 0.82% | 6.14% | 16.99% | 20.76% | -6.52% | -6.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mettler-Toledo | -7.42% | -1.61% | 36.70% | 330.61% | 1,054.72% | 2,519.96% |
| Thermo Fisher | -19.04% | -16.91% | 14.10% | 282.16% | 1,006.36% | 1,621.87% |
Performance & Financial Health Analysis: Mettler-Toledo vs Thermo Fisher
| Metric | MTD | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $27.03B | $184.66B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 146,798 | 2,008,780 |
| 90 Day Avg. Volume | 163,783 | 2,910,363 |
| Last Close | $1,312.34 | $489.01 |
| 52 Week Range | $946.69 - $1,521.01 | $385.46 - $627.88 |
| % from 52W High | -13.72% | -22.12% |
| All-Time High | $1,714.75 (Dec 27, 2021) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -23.47% | -27.27% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.03% |
| Quarterly Earnings Growth | -0.09% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.15% |
| Operating Margin (TTM) | 0.27% | 0.18% |
| Return on Equity (TTM) | -6.80% | 0.13% |
| Debt to Equity (MRQ) | -8.44 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-12.56 | $133.77 |
| Cash per Share (MRQ) | $3.00 | $16.92 |
| Operating Cash Flow (TTM) | $951.67M | $7.58B |
| Levered Free Cash Flow (TTM) | $689.75M | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.31% |
| Last 12-Month Dividend | N/A | $1.21 |
Valuation & Enterprise Metrics Analysis: Mettler-Toledo vs Thermo Fisher
| Metric | MTD | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 33.22 | 28.25 |
| Forward P/E | 30.81 | 20.82 |
| PEG Ratio | 30.81 | 4.97 |
| Price to Sales (TTM) | 6.99 | 4.27 |
| Price to Book (MRQ) | N/A | 3.66 |
| Market Capitalization | ||
| Market Capitalization | $27.03B | $184.66B |
| Enterprise Value | $29.16B | $213.59B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.54 | 4.94 |
| Enterprise to EBITDA | 24.59 | 19.74 |
| Risk & Other Metrics | ||
| Beta | 1.35 | 0.75 |
| Book Value per Share (MRQ) | $-12.56 | $133.77 |
Financial Statements Comparison: Mettler-Toledo vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MTD | TMO |
|---|---|---|
| Revenue/Sales | $983.22M | $10.36B |
| Cost of Goods Sold | $403.35M | $6.13B |
| Gross Profit | $579.88M | $4.24B |
| Research & Development | $49.29M | $342.00M |
| Operating Income (EBIT) | $265.71M | $1.82B |
| EBITDA | $299.44M | $2.73B |
| Pre-Tax Income | $248.66M | $1.62B |
| Income Tax | $46.31M | $95.00M |
| Net Income (Profit) | $202.35M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MTD | TMO |
|---|---|---|
| Cash & Equivalents | $64.29M | $4.13B |
| Total Current Assets | $1.16B | $23.38B |
| Total Current Liabilities | $1.15B | $13.17B |
| Long-Term Debt | $1.89B | $31.37B |
| Total Shareholders Equity | $-181.98M | $49.49B |
| Retained Earnings | $8.53B | $54.45B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MTD | TMO |
|---|---|---|
| Operating Cash Flow | $228.93M | $2.15B |
| Capital Expenditures | $-17.26M | $-350.00M |
| Free Cash Flow | $177.19M | $361.00M |
| Debt Repayment | $-479.33M | $-838.00M |
| Common Stock Repurchase | $-218.75M | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | MTD | TMO |
|---|---|---|
| Shares Short | 683,541 | 3.71M |
| Short Ratio | 4.48 | 1.14 |
| Short % of Float | 0.04% | 0.01% |
| Average Daily Volume (10 Day) | 146,798 | 2,008,780 |
| Average Daily Volume (90 Day) | 163,783 | 2,910,363 |
| Shares Outstanding | 20.95M | 380.77M |
| Float Shares | 20.25M | 376.76M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 1.05% | 0.92% |
Dividend Analysis & Yield Comparison: Mettler-Toledo vs Thermo Fisher
| Metric | MTD | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.21 |
| Last 12-Month Dividend Yield | N/A | 0.31% |
| 3-Year Avg Annual Dividend | N/A | $1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $3.99 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |